Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.

Standard

Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. / Höcker, Britta; Kovarik, John M; Daniel, Volker; Opelz, Gerhard; Fehrenbach, Henry; Holder, Martin; Hoppe, Bernd; Hoyer, Peter; Jungraithmayr, Therese C; Köpf-Shakib, Sabine; Laube, Guido F; Müller-Wiefel, Dirk E.; Offner, Gisela; Plank, Christian; Schröder, Monika; Weber, Lutz T; Zimmerhackl, Lothar B; Tönshoff, Burkhard.

in: TRANSPLANTATION, Jahrgang 86, Nr. 9, 9, 2008, S. 1234-1240.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Höcker, B, Kovarik, JM, Daniel, V, Opelz, G, Fehrenbach, H, Holder, M, Hoppe, B, Hoyer, P, Jungraithmayr, TC, Köpf-Shakib, S, Laube, GF, Müller-Wiefel, DE, Offner, G, Plank, C, Schröder, M, Weber, LT, Zimmerhackl, LB & Tönshoff, B 2008, 'Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.', TRANSPLANTATION, Jg. 86, Nr. 9, 9, S. 1234-1240. <http://www.ncbi.nlm.nih.gov/pubmed/19005405?dopt=Citation>

APA

Höcker, B., Kovarik, J. M., Daniel, V., Opelz, G., Fehrenbach, H., Holder, M., Hoppe, B., Hoyer, P., Jungraithmayr, T. C., Köpf-Shakib, S., Laube, G. F., Müller-Wiefel, D. E., Offner, G., Plank, C., Schröder, M., Weber, L. T., Zimmerhackl, L. B., & Tönshoff, B. (2008). Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. TRANSPLANTATION, 86(9), 1234-1240. [9]. http://www.ncbi.nlm.nih.gov/pubmed/19005405?dopt=Citation

Vancouver

Höcker B, Kovarik JM, Daniel V, Opelz G, Fehrenbach H, Holder M et al. Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. TRANSPLANTATION. 2008;86(9):1234-1240. 9.

Bibtex

@article{c6498390b64e46a098f8c173a2ad2f41,
title = "Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.",
abstract = "BACKGROUND: The aim of this substudy within a prospective, multicenter, placebo-controlled trial was to assess the pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on comedication with mycophenolate mofetil (MMF). METHODS: Eighty-two patients aged 3 to 18 years, receiving cyclosporine microemulsion, MMF, corticosteroids, and basiliximab or placebo were investigated. Basiliximab serum concentrations were determined by ELISA, CD25+, and CD122+ T lymphocytes by flow cytometry. RESULTS: Basiliximab clearance adjusted to body surface area was significantly (P",
author = "Britta H{\"o}cker and Kovarik, {John M} and Volker Daniel and Gerhard Opelz and Henry Fehrenbach and Martin Holder and Bernd Hoppe and Peter Hoyer and Jungraithmayr, {Therese C} and Sabine K{\"o}pf-Shakib and Laube, {Guido F} and M{\"u}ller-Wiefel, {Dirk E.} and Gisela Offner and Christian Plank and Monika Schr{\"o}der and Weber, {Lutz T} and Zimmerhackl, {Lothar B} and Burkhard T{\"o}nshoff",
year = "2008",
language = "Deutsch",
volume = "86",
pages = "1234--1240",
journal = "TRANSPLANTATION",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

RIS

TY - JOUR

T1 - Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.

AU - Höcker, Britta

AU - Kovarik, John M

AU - Daniel, Volker

AU - Opelz, Gerhard

AU - Fehrenbach, Henry

AU - Holder, Martin

AU - Hoppe, Bernd

AU - Hoyer, Peter

AU - Jungraithmayr, Therese C

AU - Köpf-Shakib, Sabine

AU - Laube, Guido F

AU - Müller-Wiefel, Dirk E.

AU - Offner, Gisela

AU - Plank, Christian

AU - Schröder, Monika

AU - Weber, Lutz T

AU - Zimmerhackl, Lothar B

AU - Tönshoff, Burkhard

PY - 2008

Y1 - 2008

N2 - BACKGROUND: The aim of this substudy within a prospective, multicenter, placebo-controlled trial was to assess the pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on comedication with mycophenolate mofetil (MMF). METHODS: Eighty-two patients aged 3 to 18 years, receiving cyclosporine microemulsion, MMF, corticosteroids, and basiliximab or placebo were investigated. Basiliximab serum concentrations were determined by ELISA, CD25+, and CD122+ T lymphocytes by flow cytometry. RESULTS: Basiliximab clearance adjusted to body surface area was significantly (P

AB - BACKGROUND: The aim of this substudy within a prospective, multicenter, placebo-controlled trial was to assess the pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on comedication with mycophenolate mofetil (MMF). METHODS: Eighty-two patients aged 3 to 18 years, receiving cyclosporine microemulsion, MMF, corticosteroids, and basiliximab or placebo were investigated. Basiliximab serum concentrations were determined by ELISA, CD25+, and CD122+ T lymphocytes by flow cytometry. RESULTS: Basiliximab clearance adjusted to body surface area was significantly (P

M3 - SCORING: Zeitschriftenaufsatz

VL - 86

SP - 1234

EP - 1240

JO - TRANSPLANTATION

JF - TRANSPLANTATION

SN - 0041-1337

IS - 9

M1 - 9

ER -